Topotecan Terminated Phase 3 Trials for Lung Cancer Small Cell Lung Cancer (SCLC) / Extensive Disease / First-Line Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00812266Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)